Coherent VersaPulse Select Is First Holmium Laser For BPH Cleared By FDA
This article was originally published in The Gray Sheet
Executive Summary
Coherent's VersaPulse Select holmium laser system, cleared by FDA via 510(k) May 20 for treatment of benign prostatic hyperplasia and available immediately, is the first holmium laser cleared for use in BPH procedures.